Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Community
SITE POLL ARCHIVE

Important Notice: Opine Online provides an informal way for the research community to express its views on current topics. The results are not a scientific poll and do not necessarily reflect the percentages of all Alzheimer researchers who agree with these positions.

November 2008
Poll Question: Are you in favor of ICAD going annual?

Yes
36
No
109
Undecided
3
Responses: 148
Comments on Site Poll
  Comment by:  Manfred Windisch (Disclosure)
Submitted 5 November 2008  |  Permalink Posted 6 November 2008

There is an inflation of meetings and it is becoming less and less attractive to go to conferences because not much new research is presented. Therefore I believe that it is enough to have a big conference like ICAD every second year.

View all comments by Manfred Windisch

  Comment by:  Martin Ingelsson
Submitted 9 November 2008  |  Permalink Posted 11 November 2008

I agree with Dr. Windisch. The conference schedule for AD and PD researchers is tight as it is and adding more conferences will not do any good to science. Also, the negative environmental impact of transporting 5,000 participants across continents should be considered.

View all comments by Martin Ingelsson

  Comment by:  Hans Basun
Submitted 12 November 2008  |  Permalink Posted 12 November 2008

The ICAD meetings have a central role by combining the best preclinical and clinical research activities covering Alzheimer and related disorders. This central position will definitively be diluted by running the conference every year.

View all comments by Hans Basun

  Comment by:  Dominic Walsh, ARF Advisor
Submitted 12 November 2008  |  Permalink Posted 12 November 2008

I don't think an annual conference is a good idea. Having more frequent meetings won't speed up breakthroughs - it simply diverts researchers' time away from designing and executing important experiments. As a consequence the standard of presentations at an annual meeting are likely to be of an incremental nature.

View all comments by Dominic Walsh

  Comment by:  M. Paul Murphy
Submitted 17 November 2008  |  Permalink Posted 17 November 2008

I have to agree with the general sentiment that this is one meeting too many. The field doesn't move fast enough to warrant a major conference every year. I anticipate that the quality will go down dramatically. Also, a good portion of us go to the AD/PD meeting which (until this year) alternates with ICAD.

View all comments by M. Paul Murphy

  Comment by:  David Holtzman
Submitted 17 November 2008  |  Permalink Posted 17 November 2008

I believe the decision of ICAD to occur annually is not in best interest of the field. Having the meeting every other year has worked well in conjunction with various other meetings in this and related fields. There are already an abundance of meetings directly or indirectly related to AD. This will diminish the importance of ICAD and will likely result in a diluted meeting.

View all comments by David Holtzman

  Comment by:  Bart De Strooper, ARF Advisor
Submitted 19 November 2008  |  Permalink Posted 19 November 2008

I do not think it is good to put an ICAD meeting so close to the AD/PD meeting. This will split the audience. Moreover, like with everything, quantity dilutes quality. I do not see what ICAD believes to gain at the scientific level from more meetings.

View all comments by Bart De Strooper

  Comment by:  Lon Schneider, ARF Advisor (Disclosure)
Submitted 18 November 2008  |  Permalink Posted 21 November 2008

The Alzheimer's Association derives substantial publicity from ICAD. The Association may be integrating its corporate identity and branding with ICAD, and may gain donations and revenue that it might not have gotten from a biannual meeting. Annualizing ICAD appears more as a business case than a scientific one. Large non-profits such as the AHA, ADA, American Psychiatric Association, can gain substantial revenue from the meetings they put on. As long as stakeholders, donors, and pharmaceutical companies pay, it will be a sound decision. Unfortunately, a yearly ICAD may marginalize the smaller AD meetings.

Despite most of us not thinking an annual ICAD is a good idea, many of us will participate anyway. Our group, for example, will submit abstracts and proposals for the Vienna meeting by the February 2 deadline even if it means forcing some things, because not to do so means we don’t play. So an annual ICAD may be a good bet for the Alzheimer’s Association—provided, that is, that the economy holds.

View all comments by Lon Schneider


  Comment by:  Michael Lardelli
Submitted 24 November 2008  |  Permalink Posted 25 November 2008

When discussing whether more frequent conferences are needed, we would do well to remember recent calls in the scientific community to reduce conference numbers because of their environmental/climate change impacts. For example, please refer to the commentary in Trends in Genetics by Hervé Philippe.

View all comments by Michael Lardelli

  Comment by:  Samuel Gandy
Submitted 26 November 2008  |  Permalink Posted 28 November 2008

As immediate past chair of the National Medical and Scientifc Advisory Council, my bias toward the Alzheimer's Association goes without saying.

The surprising thing to me about the reaction to "ICAD going annual" is that ICAD already went annual, several years ago, when the International Conference on Prevention of Dementia was founded. Attendance at ICPD has been strong; reviews have been largely favorable.

The two changes are that the "P" is now an "A", and the "ICAD" meeting will not always be held in D.C. as it has been in its previous iterations as "ICPD".

The points raised are thoughtful and understandable, but I think that this ship has sailed.

View all comments by Samuel Gandy


  Comment by:  David Small
Submitted 30 November 2008  |  Permalink Posted 1 December 2008

I agree with the general sentiment expressed here, that this meeting is one too many in 2009. Sam (Gandy) is right that previous annual meetings have worked. However the environment today is different. We now have more meetings. The ADPD meeting is now much stronger, and to have two large meetings (ADPD and ICAD) just a few months apart and only 250 km apart (150 miles for the metrically challenged) is unfortunate. Scientific meetings should be based on the need to report scientific progress, not be scheduled for reasons of fund raising. How can the field have moved forward significantly in 4 months?

View all comments by David Small

  Comment by:  Farhan Ul Haq Subhani (Disclosure)
Submitted 27 May 2009  |  Permalink Posted 2 June 2009

I believe that scientific activity now is developing results more strongly than it did previously. The occurrence of ICAD on an annual basis is a chance to integrate the scientific knowledge.

View all comments by Farhan Ul Haq Subhani

  Comment by:  Magdalena Sastre
Submitted 8 June 2009  |  Permalink Posted 8 June 2009

I think the ICAD should be scheduled every other year. It is extremely expensive and most scientists working at universities cannot afford it.

View all comments by Magdalena Sastre
Submit a Comment on this Site Poll
Cast your vote and/or make a comment on this poll. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad